Interojo Co Ltd
KOSDAQ:119610
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
24 900
34 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Interojo Co Ltd
Additional Paid In Capital
Interojo Co Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Additional Paid In Capital
₩39.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
27%
|
CAGR 10-Years
14%
|
|
|
SD Biosensor Inc
KRX:137310
|
Additional Paid In Capital
₩913.1B
|
CAGR 3-Years
128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Additional Paid In Capital
₩32.2B
|
CAGR 3-Years
59%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Additional Paid In Capital
₩432.5B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
24%
|
CAGR 10-Years
35%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Additional Paid In Capital
₩28B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
116%
|
CAGR 10-Years
N/A
|
|
|
H
|
Humasis Co Ltd
KOSDAQ:205470
|
Additional Paid In Capital
₩24.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Interojo Co Ltd
Glance View
INTEROJO, Inc. engages in the manufacture and sale of contact lenses. The company is headquartered in Pyeongtaek, Gyeonggi-Do. The company went IPO on 2010-07-28. The Company’s products include silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, rigid gas permeable (RGP) contact lenses and solutions. The firm distributes its products in domestic and overseas markets.
See Also
What is Interojo Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
39.7B
KRW
Based on the financial report for Sep 30, 2024, Interojo Co Ltd's Additional Paid In Capital amounts to 39.7B KRW.
What is Interojo Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
14%
Over the last year, the Additional Paid In Capital growth was -1%. The average annual Additional Paid In Capital growth rates for Interojo Co Ltd have been 1% over the past three years , 27% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
